Stricken Endo Eyes $6bn Debt Cut With Bankruptcy Filing And Restructuring
As Company Pens Nationwide Agreement-In-Principle To Settle US Opioid Claims
A group of Endo debtholders are looking to buy the firm out of bankruptcy, with an initial $6bn bid for the stricken firm that envisions setting aside more than half-a-billion dollars for opioid-related claims. Meanwhile, Endo has reached an agreement-in-principle to resolve opioid-related claims.
